Study Title
Intravitreal Melphalan for Intraocular Retinoblastoma
Protocol ID
ARET2121
Disease (Sub Disease)
Retinoblastoma
Diagnosis Stage
Newly diagnosed
Location
WA
Sponsor
Children's Oncology Group
Links
Trial Status
Open
Sites
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 18 Years
International registry ID's
NCT05504291
| Study Title | Intravitreal Melphalan for Intraocular Retinoblastoma |
|---|---|
| Protocol ID | ARET2121 |
| Disease (Sub Disease) | Retinoblastoma |
| Diagnosis Stage | Newly diagnosed |
| Location | WA |
| Sponsor | Children's Oncology Group |
| Links | https://clinicaltrials.gov/ct2/show/NCT05504291 |
| Trial Status | Open |
| Sites | Perth Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | up to 18 Years |
| International registry ID's | NCT05504291 |